Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
Vrionis
F D
FD
Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Wikstrand
C J
CJ
Bigner
D D
DD
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology; D011508:Chondroitin Sulfate Proteoglycans / Q000276:immunology; D005109:Extracellular Matrix / Q000276:immunology; D005732:Gangliosides / Q000276:immunology; D005910:Glioma / Q000175:diagnosis / Q000276:immunology*; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D051379:Mice; D009857:Oncogenes; D011506:Proteins / Q000276:immunology; D019063:Tenascin; D018800:Thy-1 Antigens
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D011508:Chondroitin Sulfate Proteoglycans; D005732:Gangliosides; D006133:Growth Substances; D011506:Proteins; D019063:Tenascin; D018800:Thy-1 Antigens